rs727504300

Variant summary

Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PVS1PM2BP6

The NM_000432.4(MYL2):​c.45_46delinsT​(p.Asn16ThrfsTer34) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: not found (cov: 32)

Consequence

MYL2
NM_000432.4 frameshift

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 7.76
Variant links:
Genes affected
MYL2 (HGNC:7583): (myosin light chain 2) This gene encodes a major sarcomeric protein in mammalian striated muscle. The encoded protein plays a role in embryonic heart muscle structure and function, while phosphorylation of the encoded protein is involved in cardiac myosin cycling kinetics, torsion and function in adults. Mutations in this gene are associated with hypertrophic cardiomyopathy 10 and infant-onset myopathy. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 9 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 55 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 12-110919151-TG-A is Benign according to our data. Variant chr12-110919151-TG-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 177719.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYL2NM_000432.4 linkuse as main transcriptc.45_46delinsT p.Asn16ThrfsTer34 frameshift_variant 2/7 ENST00000228841.15
MYL2NM_001406745.1 linkuse as main transcriptc.45_46delinsT p.Asn16ThrfsTer27 frameshift_variant 2/6
MYL2NM_001406916.1 linkuse as main transcriptc.-13_-12delinsT 5_prime_UTR_variant 2/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYL2ENST00000228841.15 linkuse as main transcriptc.45_46delinsT p.Asn16ThrfsTer34 frameshift_variant 2/71 NM_000432.4 P1
MYL2ENST00000546404.1 linkuse as main transcriptc.45_46delinsT p.Asn16ThrfsTer61 frameshift_variant 2/22
MYL2ENST00000548438.1 linkuse as main transcriptc.45_46delinsT p.Asn16ThrfsTer27 frameshift_variant 2/63
MYL2ENST00000663220.1 linkuse as main transcriptc.-13_-12delinsT 5_prime_UTR_variant 2/7

Frequencies

GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJul 08, 2016Variant classified as Uncertain Significance - Favor Pathogenic. The p.Asn16fs v ariant in MYL2 has been identified by our laboratory in 1 individual with HCM. I t has also been identified in 1/66542 European chromosomes by the Exome Aggregat ion Consortium (ExAC, http://exac.broadinstitute.org). This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 16 and leads to a premature termination codon 34 amino acids downst ream. This alteration is then predicted to lead to a truncated or absent protein . However, loss of function is not an established disease mechanism for this gen e at this time. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Asn16fs variant is uncertain. -
Hypertrophic cardiomyopathy 10 Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeFeb 10, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs727504300; hg19: chr12-111356955; API